SCHEMBL12136338

SCHEMBL12136338

Cc1nc(N)nc(-c2cc(Cl)cc(C(=O)N(C)C)c2)c1C#Cc1ccc(N)nc1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MTOR P42345 20/20 0.81
PIK3CA P42336 14/20 0.81
CCNE1 P24864 1/20 0.51
CDK2 P24941 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12136351 0.90 MTOR (0.66) MTORPIK3CACCNE1CDK2
SCHEMBL6893278 0.90 MTOR (1.00) MTORPIK3CACCNE1CDK2
SCHEMBL12136349 0.89 MTOR (0.64) MTORPIK3CACCNE1CDK2
SCHEMBL12136369 0.87 MTOR (0.61) MTORPIK3CA
SCHEMBL12136214 0.83 MTOR (0.71) MTORPIK3CACCNE1CDK2
SCHEMBL12136353 0.83 MTOR (0.71) MTORPIK3CACCNE1CDK2
SCHEMBL12137597 0.82 MTOR (0.60) MTORPIK3CACCNE1CDK2
SCHEMBL12136138 0.81 MTOR (0.81) MTORPIK3CACCNE1CDK2
SCHEMBL12135331 0.80 PIK3CA (0.55) MTORPIK3CA
SCHEMBL17928865 0.79 MTOR (0.60) MTORPIK3CACCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323992-B1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INT (DE) 2016-07-20 EP disclosed
US-8916548-B2 5-alkynyl-pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 US disclosed
US-8916548-B2 5-alkynyl-pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 US disclosed
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 MTOR 1488/4885PIK3CA 1567/4885CCNE1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.